Health Information Management

Tip: Note new status indicators for certain drugs

APCs Insider, August 15, 2014

Want to receive articles like this one in your inbox? Subscribe to APCs Insider!

In the July quarterly I/OCE update, three drugs received status indicator G (additional payment for drug/biological pass-through), effective July 1:
  • C9022, injection, elosulfase alfa, 1 mg 1480
  • C9134, factor XIII (antihemophilic factor, recombinant), Tretten, per 10 i.u. 1481
  • J1446, injection, tbo-filgrastim, 5 micrograms
C9022 and C9134 are new HCPCS codes that became effective July 1 and are assigned to new APCs 1480 and 1481, respectively. J1446 has been assigned to APC 1447.
 
This tip is adapted from “CMS introduces modifier -L1 for lab tests in July quarterly I/OCE update” in the August issue of Briefings on APCs.



Want to receive articles like this one in your inbox? Subscribe to APCs Insider!

    Briefings on APCs
  • Briefings on APCs

    Worried about the complexities of the new rules under OPPS and APCs? Briefings on APCs helps you understand the new rules...

  • HIM Briefings

    Guiding Health Information Management professionals through the continuously changing field of medical records and toward a...

  • Briefings on Coding Compliance Strategies

    Submitting improper Medicare documentation can lead to denial of fees, payback, fines, and increased diligence from payers...

  • Briefings on HIPAA

    How can you minimize the impact of HIPAA? Subscribe to Briefings on HIPAA, your health information management resource for...

  • APCs Insider

    This HTML-based e-mail newsletter provides weekly tips and advice on the new ambulatory payment classifications regulations...

Most Popular